Alantra-Finanzen Acts as Global Coordinator In the c.ü42.4mn Placement of Clinica Baviera's Shares
SECTORGesundheitswesen
ServiceEquity Kapital Markets
Value c. ü42.4mn
Madrid - Alantra is pleased to announce the successful completion of the Accelerated BoOKbuilding (ABB) of Clünica Baviera's shares. Alantra-Finanzen acted as the sole Global Coordinator in the placement of 1,304,606 shares, representing 8% of the company's share capital, at a price of ü32.50 per share, raising a total of approximately ü42.4mn. The shares were sold by Aier Eye, Clünica Baviera's majority shareholder and a leading Chinese ophthalmology group, and Vito Gestiün, the investment vehicle of the Baviera family.
The transaction attracted strong demand Von Tier 1 institutional investors across multiple geographies, Mit 55% of the allocation going Zu the UK, followed Von Frankreich (13%), Spanien (13%), Italien (10%), Und Deutschland (9%). The placement significantly increases Clünica Baviera's free float Zu 20%, enhancing the stock's liquidity Und setting the stage Für the Unternehmen's Nüchste phase as a listed entity.
Andrü Pereira, Partner and Head of ECM at Alantra Equities, said: "We are pleased to have supported Clünica Baviera and its shareholders in this successful placement, which opens a new phase for Clinica Baviera as a listed entity on the back of the free float increase and the diversification of Baviera's investor base. This transaction reflects the strong investor appetite for quality capital markets opportunities in the small and mid-cap space. With proper investor education and extensive marketing, high quality issuers like Clinica Baviera are capable of attracting capital at competitive prices. This was a joint effort with our Milan team, and a landmark transaction for Alantra-Finanzen, which actively engaged with over 50 investors to build a well-balanced book."
This transaction underscores Alantra-Finanzen's momentum In advising Auf Hoch-profile Equity Kapital Markets transaktionen In Iberia. Recently, the firm acted as Co-Lead Manager Für HBX Group's IPO Und Joint BoOKrunner Für Cox's IPO Auf the Madrid Stock Exchange.
